Neurocrine Biosciences
NBIX
#1396
Rank
โ‚น1.088 T
Marketcap
โ‚น10,753
Share price
-0.07%
Change (1 day)
7.71%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

EPS for Neurocrine Biosciences (NBIX)

EPS in 2023 (TTM): โ‚น162.41

According to Neurocrine Biosciences 's latest financial reports the company's current EPS (TTM) is โ‚น166.34. In 2022 the company made an earnings per share (EPS) of โ‚น136.63 an increase over its 2021 EPS that were of โ‚น80.62.

EPS history for Neurocrine Biosciences from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น162.4118.86%
2022โ‚น136.6369.47%
2021โ‚น80.62-78.21%
2020โ‚น370.02990%
2019โ‚น33.9581.82%
2018โ‚น18.67-113.5%
2017-โ‚น138.330.62%
2016-โ‚น137.4857.28%
2015-โ‚น87.4125.61%
2014-โ‚น69.5918.84%
2013-โ‚น58.56-1085.71%
2012โ‚น5.94-89.71%
2011โ‚น57.71-500%
2010-โ‚น14.43-86.92%
2009-โ‚น110.33-43.48%
2008-โ‚น195.19-57.8%
2007-โ‚น462.5292.58%
2006-โ‚น240.17371.67%
2005-โ‚น50.92-52.76%
2004-โ‚น107.7836.56%
2003-โ‚น78.93-70%
2002-โ‚น263.08118.31%
2001-โ‚น120.518.4%
2000-โ‚น111.1748.86%
1999-โ‚น74.68-20%
1998-โ‚น93.35-479.31%
1997โ‚น24.61

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น177.37 6.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น46.68-71.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
-โ‚น251.20-251.02%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น460.76 177.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น312.36 87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น157.85-5.10%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น39.89-123.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น257.14-254.59%๐Ÿ‡บ๐Ÿ‡ธ USA